In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development, the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara Rosen, is currently somewhere between dream and road to reality. Fantastic promises have been made over the years in the press and reports of startup concerns. However, slowly but surely real revenues are appearing, and realistic models for future growth will be seen.

1. World Market for Personalized Medicine Diag
, Tumor Assays, Cardiac Risk and
Other Testing)
Report Information: Executive Summary,
Competition, Marketing & Consumer &
Market Trends

2. About Us
MarketResearch.com is the world's largest and continuously updated collection of
market research. As your single source for market intelligence, we offer more than
300,000 market research reports from over 700 leading global publishers.
Our Research Specialists have in-depth knowledge of the publishers and the various
types of reports in their respective industries. They give you unbiased and qualitative
insights on which reports will best meet your needs.
Whether you’re looking for new product trends or competitive analysis of a new or
existing market, MarketResearch.com has the best research offerings and the expertise
to make sure you get the right report every time. Don’t limit your choices. See why
leading companies trust MarketResearch.com again and again to gain and maintain a
competitive edge in new and existing markets.

3. World Market for Personalized Medicine Diagnostics (Biomarkers,
Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other
Testing)
In this market research report, Kalorama Information defines the current opportunity and
a realistic future potential for personalized medicine in clinical testing. In addition to
analysis of tests currently on the market and in development, the report profiles key
competitors and discusses trends that are important for understanding this much-
discussed growth area of the diagnostic industry.
The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics
industry analyst Shara Rosen, is currently somewhere between dream and road to
reality. Fantastic promises have been made over the years in the press and reports of
startup concerns. However, slowly but surely real revenues are appearing, and realistic
models for future growth will be seen.
Developments that are linked in the press to 'personalized medicine' are many, and can
at times be confusing. But there are several discovered biomarkers that are important in
diagnostic markets.

4. World Market for Personalized Medicine Diagnostics (Biomarkers,
Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other
Testing)
Biomarkers discussed in the report include :
 Cytochrome P450 and Drug Metabolism
 Estrogen Receptor and Progesterone
 Receptor Status for Breast Cancer
 HER2 Overexpression and Herceptin and Tykerb
 Epidermal Growth Factor Receptor (EGFR)
 KRAS Mutations and Anti-EGFR Therapy for Colorectal Cancer
 BRAF Mutations and Cancer Therapy
 UGT1A1 Genetic Variants
 5-Flurouracil Therapy
 PIK3CA Genetic Variation
 KIF6 Genetic Variation
 ALK Genetic Variation
View Full Table of Contents

5. For More this Report and Additional Research
Visit MarketResearch.com
Or call
1-800-298-5699